搜尋結果
BRIDGEWATER, N.J., July 29 / PRNewswire-FirstCall / -- Sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) approved Sculptra Aesthetic (injectable poly-L-lactic acid) for the correction of shallow to deep nasolabial fold (smile lines) contour deficiencies and other facial wrinkles which are treated with the ...
2021年12月13日 · SCULPTRA is an injectable biostimulator containing microparticles of Poly-L-Lactic Acid (PLLA) which helps gradually revitalize the skin’s structural foundation, providing natural-looking, long-term results for up to 2 years*. 1-3 SCULPTRA was first approved for
Sculptra is a proprietary formulation of poly- L -lactic acid (PLLA) that is an FDA -approved dermal filler manufactured by Dermik Laboratories, which conducts the American business of Aventis Dermatology, the global dermatology unit of Aventis (of Sanofi-Aventis ). PLLA was approved by the FDA on August 3, 2004, for the treatment of ...
2021年3月4日 · Sculptra® is an injectable biostimulator containing microparticles of Poly-L-Lactic Acid (PLLA) which gradually revitalizes the skin’s structural foundation, providing natural-looking, long-term results for up to 25 months. Sculptra® was first approved in 1999 in Europe and it is currently available in more than 40 countries globally.
Sculptra (R) is a synthetic, biocompatible, bioabsorbable material that is naturally broken down by the body over time. It was approved in the U.S. in 2004 for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus.
2023年5月31日 · Sculptra is a gel implant or dermal filler that is injected into specific areas of facial tissue. It consists of the chemicals poly-L-lactic acid (PLLA), carboxymethylcellulose, and non-pyrogenic...
2023年4月26日 · Sculptra is the first and original FDA-approved PLLA collagen stimulator that, when injected into the cheek area, helps stimulate natural collagen production to smooth wrinkles and improve skin...
